Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Epilepsy | 16 | 2019 | 1401 | 3.20 | Why? |
| Anticonvulsants | 12 | 2019 | 634 | 2.38 | Why? |
| Seizures | 8 | 2018 | 1163 | 2.02 | Why? |
| Amyotrophic Lateral Sclerosis | 11 | 2018 | 398 | 1.46 | Why? |
| Social Skills | 1 | 2019 | 76 | 0.76 | Why? |
| Social Adjustment | 1 | 2019 | 77 | 0.75 | Why? |
| Epilepsy, Generalized | 2 | 2017 | 16 | 0.75 | Why? |
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 28 | 0.69 | Why? |
| Diazepam | 1 | 2017 | 45 | 0.69 | Why? |
| Sirtuin 3 | 1 | 2017 | 14 | 0.69 | Why? |
| Midazolam | 1 | 2017 | 79 | 0.67 | Why? |
| Accidental Falls | 2 | 2018 | 448 | 0.63 | Why? |
| Cell Phone Use | 1 | 2017 | 106 | 0.63 | Why? |
| Apolipoproteins E | 1 | 2017 | 170 | 0.60 | Why? |
| Parkinson Disease | 2 | 2018 | 1414 | 0.59 | Why? |
| Survivorship | 1 | 2017 | 106 | 0.59 | Why? |
| Nervous System Diseases | 5 | 2021 | 4092 | 0.56 | Why? |
| Stem Cell Transplantation | 2 | 2017 | 531 | 0.55 | Why? |
| Infant, Newborn, Diseases | 1 | 2018 | 394 | 0.54 | Why? |
| Status Epilepticus | 4 | 2019 | 303 | 0.53 | Why? |
| Multiple Sclerosis | 3 | 2018 | 2600 | 0.51 | Why? |
| Neurology | 4 | 2021 | 1613 | 0.51 | Why? |
| Brain Neoplasms | 2 | 2017 | 669 | 0.51 | Why? |
| Stroke | 4 | 2021 | 8839 | 0.48 | Why? |
| Genetic Therapy | 1 | 2017 | 409 | 0.47 | Why? |
| Aging | 2 | 2018 | 3581 | 0.44 | Why? |
| Urinary Bladder Neoplasms | 1 | 2017 | 614 | 0.41 | Why? |
| Social Stigma | 1 | 2019 | 1049 | 0.41 | Why? |
| Cell Phone | 1 | 2017 | 750 | 0.39 | Why? |
| Kidney Neoplasms | 1 | 2017 | 832 | 0.36 | Why? |
| Geriatric Assessment | 1 | 2017 | 1372 | 0.35 | Why? |
| Postural Balance | 2 | 2018 | 144 | 0.33 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.32 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.29 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.28 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.27 | Why? |
| Incidence | 12 | 2021 | 25622 | 0.27 | Why? |
| Epilepsy, Post-Traumatic | 1 | 2003 | 4 | 0.26 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.26 | Why? |
| Community Health Planning | 2 | 2018 | 164 | 0.24 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.21 | Why? |
| Dementia | 3 | 2018 | 1861 | 0.21 | Why? |
| Research Design | 2 | 2016 | 5830 | 0.20 | Why? |
| Electroencephalography | 4 | 2018 | 1242 | 0.19 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.19 | Why? |
| Humans | 58 | 2021 | 930598 | 0.18 | Why? |
| Psychophysiologic Disorders | 1 | 2018 | 69 | 0.18 | Why? |
| Administration, Buccal | 1 | 2017 | 17 | 0.18 | Why? |
| Psychomotor Agitation | 1 | 2020 | 208 | 0.18 | Why? |
| Administration, Rectal | 1 | 2017 | 17 | 0.18 | Why? |
| Remission Induction | 2 | 2019 | 950 | 0.18 | Why? |
| Hypoxia, Brain | 1 | 2018 | 92 | 0.18 | Why? |
| Progestins | 1 | 2017 | 43 | 0.18 | Why? |
| Brain Injuries | 1 | 2003 | 374 | 0.17 | Why? |
| Economics, Pharmaceutical | 1 | 2017 | 61 | 0.17 | Why? |
| Contraceptives, Oral, Hormonal | 1 | 2017 | 42 | 0.17 | Why? |
| Intracranial Arteriovenous Malformations | 1 | 2017 | 71 | 0.17 | Why? |
| Estrogen Replacement Therapy | 1 | 2017 | 50 | 0.17 | Why? |
| Italy | 14 | 2020 | 38444 | 0.17 | Why? |
| Paresis | 1 | 2017 | 77 | 0.17 | Why? |
| Somatoform Disorders | 1 | 2018 | 153 | 0.16 | Why? |
| Clinical Trials as Topic | 1 | 2016 | 7330 | 0.16 | Why? |
| Gait | 1 | 2017 | 137 | 0.16 | Why? |
| Frontotemporal Dementia | 1 | 2017 | 55 | 0.16 | Why? |
| Leisure Activities | 1 | 2018 | 221 | 0.16 | Why? |
| Drug Resistant Epilepsy | 1 | 2017 | 106 | 0.15 | Why? |
| Intensive Care, Neonatal | 1 | 2018 | 284 | 0.15 | Why? |
| Electric Stimulation Therapy | 1 | 2017 | 151 | 0.15 | Why? |
| Decision Trees | 1 | 2017 | 441 | 0.15 | Why? |
| Craniocerebral Trauma | 1 | 2017 | 160 | 0.15 | Why? |
| Upper Extremity | 1 | 2017 | 193 | 0.15 | Why? |
| Infant | 7 | 2019 | 30274 | 0.15 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.14 | Why? |
| Movement Disorders | 1 | 2017 | 186 | 0.14 | Why? |
| Eating | 1 | 2017 | 395 | 0.14 | Why? |
| Habits | 1 | 2017 | 334 | 0.14 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.14 | Why? |
| Educational Status | 2 | 2018 | 1451 | 0.14 | Why? |
| Estrogens | 1 | 2017 | 252 | 0.14 | Why? |
| Male | 31 | 2021 | 367725 | 0.13 | Why? |
| Stroke Rehabilitation | 1 | 2017 | 299 | 0.13 | Why? |
| Life Style | 2 | 2017 | 2708 | 0.13 | Why? |
| Drug Utilization | 1 | 2019 | 619 | 0.13 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2016 | 801 | 0.13 | Why? |
| Female | 31 | 2021 | 380317 | 0.13 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.13 | Why? |
| Risk Factors | 13 | 2020 | 71621 | 0.12 | Why? |
| Aged | 23 | 2021 | 215776 | 0.12 | Why? |
| Egypt | 1 | 2017 | 1211 | 0.12 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2016 | 782 | 0.12 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.12 | Why? |
| Bias | 1 | 2018 | 1109 | 0.12 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2016 | 422 | 0.12 | Why? |
| Recurrence | 2 | 2019 | 3675 | 0.12 | Why? |
| Ireland | 4 | 2018 | 1456 | 0.12 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.11 | Why? |
| Neurons | 1 | 2017 | 864 | 0.11 | Why? |
| Adolescent | 11 | 2020 | 86841 | 0.11 | Why? |
| Child | 9 | 2019 | 70012 | 0.10 | Why? |
| Case-Control Studies | 7 | 2018 | 17671 | 0.10 | Why? |
| Child, Preschool | 6 | 2019 | 36283 | 0.10 | Why? |
| Headache | 1 | 2020 | 2257 | 0.10 | Why? |
| Adult | 19 | 2021 | 244371 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
| Consensus | 3 | 2020 | 6345 | 0.09 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.09 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.09 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.09 | Why? |
| Immunomodulation | 1 | 2017 | 1472 | 0.09 | Why? |
| Registries | 4 | 2021 | 12327 | 0.08 | Why? |
| Exercise | 2 | 2018 | 6771 | 0.08 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.08 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.08 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| New Zealand | 3 | 2019 | 2073 | 0.08 | Why? |
| Odds Ratio | 4 | 2021 | 5861 | 0.08 | Why? |
| Patient Care | 1 | 2017 | 1664 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Prospective Studies | 4 | 2019 | 43301 | 0.07 | Why? |
| Research | 1 | 2019 | 2115 | 0.07 | Why? |
| Finland | 2 | 2018 | 671 | 0.07 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.07 | Why? |
| Referral and Consultation | 2 | 2020 | 4816 | 0.07 | Why? |
| Neurosurgical Procedures | 1 | 2017 | 1738 | 0.07 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.07 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.07 | Why? |
| Frailty | 1 | 2017 | 1432 | 0.07 | Why? |
| Age of Onset | 2 | 2017 | 557 | 0.07 | Why? |
| Aged, 80 and over | 8 | 2020 | 88759 | 0.07 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Sleep | 1 | 2017 | 2695 | 0.07 | Why? |
| Netherlands | 3 | 2018 | 3533 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.06 | Why? |
| Insurance, Health | 2 | 2018 | 634 | 0.06 | Why? |
| Comorbidity | 2 | 2017 | 34796 | 0.06 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.06 | Why? |
| Glutamic Acid | 1 | 2001 | 65 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Databases, Factual | 1 | 2015 | 6248 | 0.05 | Why? |
| Brain | 1 | 2017 | 5133 | 0.05 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Surveys and Questionnaires | 5 | 2018 | 43792 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.04 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.04 | Why? |
| Europe | 3 | 2020 | 12702 | 0.04 | Why? |
| Serbia | 1 | 2017 | 227 | 0.04 | Why? |
| Coma | 1 | 2018 | 204 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2017 | 291 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Prodromal Symptoms | 1 | 2017 | 133 | 0.04 | Why? |
| Coffee | 1 | 2017 | 79 | 0.04 | Why? |
| Delphi Technique | 1 | 2020 | 1257 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2017 | 15421 | 0.04 | Why? |
| Neural Stem Cells | 1 | 2016 | 135 | 0.04 | Why? |
| Cross-Cultural Comparison | 1 | 2018 | 338 | 0.04 | Why? |
| Energy Intake | 1 | 2017 | 323 | 0.04 | Why? |
| Anesthetics | 1 | 2018 | 196 | 0.04 | Why? |
| Alcohol Drinking | 2 | 2017 | 1663 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Disability Evaluation | 1 | 2017 | 671 | 0.03 | Why? |
| Primary Prevention | 1 | 2021 | 778 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Depression | 1 | 2018 | 14116 | 0.03 | Why? |
| European Union | 1 | 2017 | 565 | 0.03 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.03 | Why? |
| Animals | 2 | 2017 | 78931 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2018 | 1340 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.03 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2020 | 9893 | 0.02 | Why? |
| Blood Platelets | 1 | 2001 | 1704 | 0.02 | Why? |
| Alcoholism | 1 | 1997 | 691 | 0.02 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.02 | Why? |
| Health Surveys | 1 | 2020 | 2841 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.02 | Why? |
| Safety | 1 | 2016 | 1583 | 0.02 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2018 | 1529 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.02 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.02 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Analysis of Variance | 1 | 2001 | 950 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Data Collection | 1 | 1997 | 1769 | 0.01 | Why? |
Beghi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_